Chronic kidney disease (CKD) is a widespread condition that affects millions of people in the United States, an estimated 37 million people. However, due to its asymptomatic nature in the early stages, many individuals are unaware they have CKD until it reaches an advanced stage. This silent epidemic not only poses a threat to public health but also contributes significantly to healthcare expenditure.
In this whitepaper, we will explore the impact of CKD progression on healthcare costs and discuss the importance of early detection and management using the MedInsight® Chronic Conditions Hierarchical Groups (CCHGs) grouper.
